Health Condition 1: D539- Nutritional anemia, unspecified
Conditions
Interventions
None listed
Sponsors
Dr Sakshi Shrivastava
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with the Haemoglobin Range of below 11 gm/dl 2. Patients willing to participate in this trial through written informed consent 3. According to modern concepts, the Megaloblastic type of Anemia will be taken for the study
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with hyper/hypo-tension, diabetes mellitus of any type, hyper/hypothyroidism, or any other health conditions requiring regular medication. 2. Patients with significant hepatic, renal, hematological, neurological, or psychiatric disorders will be excluded from the study. 3. Individuals who have gone through any major surgery within the past 2 years. 4. Pregnant and lactating women will also be excluded from the study. 5. Other than Megaloblastic Anemia, all other types of Anemia will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in Hb% and CBC levels and symptoms of Garvishjnya Pandu will be reduced.Timepoint: 4 weeks to 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDr Ravikant Gupta
LN Ayurved College and Hospital Bhopal
Outcome results
None listed